Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Leaf and root extracts demonstrated antiplasmodial potentials in mice models, with effects being dosage and duration-dependent [PMID:34394229, PMID:34659429].
Butanol fraction of leaves reduced blood glucose levels, enhanced oral glucose tolerance, and restored insulin secretion in diabetic rats [PMID:33840309]. Stem bark aqueous extract also normalized blood glucose in diabetic mice [PMID:40999897].
Aqueous fraction of leaves suppressed carrageenan- and formaldehyde-induced rat paw edema [PMID:27974282].
Aqueous stem bark extract exhibited anticataract activity in Sprague Dawley rat models of diabetic and age-related cataracts [PMID:37560323].
Aqueous and methanol stem-bark extracts were assessed for anticolitis effects in DSS-induced intestinal colitis models [PMID:32565862].
Sécurité et effets indésirables
Synthèse des preuves
Sources PubMed
- 1.PMID: 37894548 (2023) — Antispasmodic Effect of Alstonia boonei De Wild. and Its Constituents: Ex Vivo and In Silico Approaches. · Molecules (Basel, Switzerland)
- 2.PMID: 36323654 (2023) — In vitro effects of 2-methyl-3-propylbutane-1,4-diol purified from Alstonia boonei on erythrocyte membrane stabilization and mitochondrial membrane permeabilization. · Chemical biology & drug design
- 3.PMID: 36965546 (2023) — Neuroprotection by Alstonia boonei De Wild., Anacardium occidentale L., Azadirachta indica A.Juss. and Mangifera indica L. · Journal of ethnopharmacology
- 4.PMID: 37864233 (2023) — Phytochemical analysis, in vitro and in silico effects from Alstonia boonei De Wild stem bark on selected digestive enzymes and adipogenesis in 3T3-L1 preadipocytes. · BMC complementary medicine and therapies
- 5.PMID: 37560323